Evidence map›Paper›PMID 23904056›Full record

ArticleJournal of materials science. Materials in medicine2013

Electrografting of a biodegradable layer as a primer adhesion coating onto a metallic stent: in vitro and in vivo evaluations.

Gwenaelle Vergnol, Estelle Renard, Ferial Haroun, Patrice Guerin, Aymeric Seron, Christophe Bureau, Gervaise Loirand, Valerie Langlois

Abstract read
PubMed Publisher
In one paragraph

Article in Journal of materials science. Materials in medicine, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.6field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 5 institutions in 1 country.

Gwenaelle VergnolEquipe Systèmes Polymères Complexes, Institut de Chimie et des Matériaux Paris-Est-UMR 7182, CNRS, Université Paris-Est Créteil Val-de-Marne, 2 rue Henri Dunant, 94320, Thiais, France, gvergnol@gmail.com.
Estelle Renard
Ferial Haroun
Patrice Guerin
Aymeric Seron
Christophe Bureau
Gervaise Loirand
Valerie Langlois
Association pour l'Utilisation du Rein Artificiel dans la région Lyonnaise · FRCentre National de la Recherche Scientifique · FRInserm · FRInstitut de Chimie et des Matériaux Paris-Est · FRInstitut du Thorax · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Drug-eluting stents have been developed to reduce the risk of restenosis after angioplasty. To facilitate the adhesion of a poly(lactic acid) (PLA) overlayer loaded with rapamycin (20 wt%), a biodegradable macromonomer based on poly(lactic acid) (HEMA-PLA) was grafted onto the metallic stent by electrografting in a one-step reaction involving the immobilization of aryl diazonium onto the metal followed by an in situ surface electro-polymerization. The HEMA-PLA coating was chemically characterized. Mechanical performance during stent expansion was tested. Morphology examinations showed a strong adhesion of PLA topcoat in the presence of the electrografted layer. Biocompatibility and degradation of the coating were studied in vitro and in vivo in rabbit iliac arteries. These 28 days implantations resulted in a minimal inflammatory process with a partial degradation of the coating. These results suggest that this kind of anchoring of a biodegradable layer shows great potential for drug-eluting stents.

Indexed as

Drug-Eluting StentsAngioplastyAnimalsArteriesBiocompatible MaterialsCell AdhesionCoronary RestenosisDrug Delivery SystemsElectrochemistryHumansInflammationLactic AcidMaleMetalsPolyestersPolymersBiocompatible MaterialsLactic AcidMetalsPolyesterspoly(lactide)PolymersSirolimus

Identifiers

PMID23904056
OpenAlexW2042143920

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.